BrainSense™ technology allows you to adapt to patient needs over time with data-driven insights
Designed for the needs of today and tomorrow, the Percept™ family is:
Empowering patient freedom with patient-first capabilities for flexibility and convenience
Enabling personalization with data-driven insights that allow you to adapt therapy to your patients' needs
Designed for upgradability and engineered to allow for future software updates for the Percept™ platform without a neurostimulator device exchange
DBS Percept™ family video
Percept™ PC neurostimulator
The recharge-free model blends ergonomic design with cutting-edge battery technology.
| Ergonomic design | Percept™ PC neurostimulator is designed for comfort, with the thinnest PC on the market†,1-3. |
| Designed to last | The Percept™ PC device has a projected mean longevity >5 years for median energy-user‡ and features smart battery technology offering real-time estimation of battery longevity§, to keep keep your patients informed. |
| Designed to adapt | BrainSense™ technologyΩ and advanced programming capabilities let you personalize therapy to your patients’ evolving needs over time. |
| Broad indication coverage | Indicated for: PD, ET, epilepsy, dystonia*, OCD* |
† As compared to Boston Scientific Vercise Genus P16. MP92328632-05 REV-A. As compared to St Jude Medical Infinity 5/7. IPG. ARTEN600150429 - B.
‡ For median energy use in DBS for patients with Parkinson’s disease.
§ Based on current actual battery level and therapy settings from last seven days.
*Humanitarian device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
Percept™ RC neurostimulator
Meet the newest member of the Percept™ family. Percept™ RC offers patients a rechargeable version specifically designed to be:
| Small | Patient comfort The smallest, thinnest, dual-channel DBS device available††. |
| Smart | Rapid recharging Patients can charge under normal conditions (from 10% to 90% full) in less than an hour‡‡. Greater than 99% capacity at 15 years with weekly recharge, it is designed to offer a more consistent recharge experience over time. |
| Adaptive | Designed to adapt BrainSense™ technologyΩ and advanced programming capabilities let you personalize therapy to your patients’ evolving needs over time. |
| Broad indication coverage | Indicated for: PD, ET, epilepsy, dystonia*. |
†† As compared to Boston Scientific Vercise Genus R16 and Vercise Genus P16. MP92328632-05 REV-A. As compared to St Jude Medical Infinity 5/7 IPG. ARTEN600150429 - B.
‡‡ For implant depths of up to 2.0cm.
*Humanitarian device: The effectiveness of these devices for the treatment of dystonia has not been demonstrated.
Percept™ family with exclusive BrainSense™ technology
- Uses local field potentials (LFPs) as a signal of interest that can be tracked with responses to deep brain stimulation (DBS) therapy and medications
- Offers data-driven insights into the patient’s condition enabling clinicians to adapt DBS to a patient’s needs
- Engineered for future software updates that allow patients to have access to additional features without a device exchange
BrainSense™ technology offers decision-making support to select and optimize programming configurations and maximize therapeutic results over time.
A vast majority of patients with Parkinson’s disease have a detectable signal (LFP).4
92%
have a detectable signal in an “off-medication” state4
87%
of brain hemispheres have a detectable signal in an “on-medication” state4
15+ years
of research has informed BrainSense™ technology
Your DBS patient may need an MRI
~10M
scans in the U.S. performed annually5
77%
MRI scans ordered globally are not brain-related.6
1 in 8
women will develop breast cancer7
Full-body MRI access§§
- Medtronic offers greater freedom and scan access with 3T scans and best-in-class 1.5T MRI scan labeling8-10 for directional leads.
- Even when having an MRI, Medtronic DBS is the only DBS system that doesn't keep a patient from receiving the care they need.8-10
- No restrictions on prone position for breast scans with Medtronic DBS systems10
This material is for Healthcare Professionals in countries with applicable health authority product registrations.
Important: Always refer to the Instructions For Use (IFU) packaged with the product/e-IFU for complete instructions, indications, contraindications, warnings, and precautions.
Ω The sensing feature of the Percept™ PC system and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia*, epilepsy, or obsessive-compulsive disorder*.
*Humanitarian device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
§§ 
Under specific conditions. Refer to product labeling for full list of conditions: manuals.medtronic.com/manuals/mri/region
1
Implantable Pulse Generator Infinity™ IPG Clinician’s Manual ARTEN600149416 A - St Jude Medical (US Version), accessed on 01/02/24
2
Percept™ PC B35200 Neurostimulator with BrainSense™ Technology—Implant Manual M982261A015 REV A—Medtronic
3
Vercise™ Deep Brain Stimulation Systems, Surgical Implant Manual. MP92328632-05 REV A, accessed 01/02/24
4
Darcy N, Lofredi R, Al-Fatly B, et al. Spectral and spatial distribution of subthalamic beta peak activity in Parkinson’s disease patients. Experimental Neurology. 2022:114150.
5
Information for patients. International Society for Magnetic Resonance in Medicine. https://www.ismrm.org/resources/information-for-patients. Accessed December 19, 2023.
6
BCC Publishing Staff. Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets, Report Code HLC078E. BCC Research. 2021. Available at: www.bccresearch.com/market-research/healthcare/medical-magnetic-resonance-imaging-mri-technologies-and-global-markets-report.html. Accessed December 19, 2023.
7
Key Statistics for Breast Cancer. American Cancer Society Website. www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. Updated January 12, 2023. Accessed December 19, 2023
8
ImageReady™ MRI guidelines for Boston Scientific deep brain stimulation systems — 92195369-01, accessed on 01/02/2024.
9
MRI procedure information for Abbott Medical™† MR Conditional deep brain stimulation systems — ARTEN600090482 A, accessed on 01/02/2024.
10
MRI guidelines for Medtronic deep brain stimulation systems 37601 37602 37603 37612 B35200 B35300 — M929535A_a_092 https://manuals.medtronic.com/manuals/mri/region